Status:
COMPLETED
Covid-19 Pandemic: Patients' Experience in T1D
Lead Sponsor:
McGill University
Collaborating Sponsors:
Juvenile Diabetes Research Foundation
Canadian Institutes of Health Research (CIHR)
Conditions:
Type1diabetes
Covid19
Eligibility:
All Genders
1+ years
Brief Summary
Given the current situation with COVID-19 declared pandemic on March 11, 2020 and the requirement for physical distancing and to limit social interactions, and for some, to quarantine, the investigato...
Detailed Description
Recruitment of people with type 1 diabetes will be done via an email sent to the participants in the BETTER registry who agreed to be contacted for other studies. Participants of 18 years old and mor...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Having type 1 diabetes
- Living in Quebec
- Having took part in the BETTER registry (www.type1better.com)
- Exclusion criteria:
- Not understanding French or English
Exclusion
Key Trial Info
Start Date :
April 29 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2020
Estimated Enrollment :
384 Patients enrolled
Trial Details
Trial ID
NCT04384471
Start Date
April 29 2020
End Date
July 1 2020
Last Update
February 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de Recherches Cliniques de Montréal
Montreal, Quebec, Canada, H2W 1R7